ArrowMark Colorado Holdings’s Pliant Therapeutics PLRX Stock Holding History

ArrowMark Colorado Holdings’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$321K	Hold	281,189	–	–	0.01%	284
2026 Q1	$354K	Hold	281,189	–	–	0.01%	276
2025 Q4	$343K	Hold	281,189	–	–	0.01%	294
2025 Q3	$416K	Hold	281,189	–	–	0.01%	285
2025 Q2	$326K	Hold	281,189	–	–	0.01%	287
2025 Q1	$380K	Hold	281,189	–	–	0.01%	277
2024 Q4	$3.7M	Hold	281,189	–	–	0.05%	210
2024 Q3	$3.15M	Hold	281,189	–	–	0.04%	210
2024 Q2	$3.02M	Hold	281,189	–	–	0.04%	229
2024 Q1	$4.19M	Hold	281,189	–	–	0.05%	220
2023 Q4	$5.09M	Hold	281,189	–	–	0.06%	202
2023 Q3	$4.88M	Hold	281,189	–	–	0.06%	194
2023 Q2	$5.1M	Buy	+281,189	New	+$6.66M	0.06%	198

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

ArrowMark Colorado Holdings's PLRX Position: Q2 2026 in Review

ArrowMark Colorado Holdings held its Pliant Therapeutics (PLRX) position steady in Q2 2026 at 281,189 shares worth $321K. The position accounts for 0.01% of the portfolio, ranked #284.

ArrowMark Colorado Holdings first reported a position in PLRX in Q2 2023 and has held it in 13 quarters since. The position peaked at $5.1M in Q2 2023. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

ArrowMark Colorado Holdings held 281,189 shares of Pliant Therapeutics worth $321K as of Q2 2026.
ArrowMark Colorado Holdings left its Pliant Therapeutics share count unchanged in Q2 2026.
Pliant Therapeutics made up 0.01% of ArrowMark Colorado Holdings's portfolio in Q2 2026, its #284 holding.
ArrowMark Colorado Holdings first reported a position in Pliant Therapeutics in Q2 2023 and has held it in 13 quarters since.
ArrowMark Colorado Holdings's Pliant Therapeutics position peaked at $5.1M in Q2 2023.
86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on ArrowMark Colorado Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.